FDA Using Ion Mobility Spectrometers In 4 IMFs, Plans Use In 4 More

Across all 9 IMF facilities in FY 2019, FDA screened around 25,200 parcels containing more than 41,000 products, detained more than 38,000 including 1,801 identified as supplements and expects to destroy more than 17,000.

Stop barrier

More from Regulation

More from Policy & Regulation